Reducing time from symptom onset to reperfusion therapy decreases infarct size and improves survival in patients with ST-elevation myocardial infarction (STEMI). National quality improvement initiatives, including the Door-toBalloon (D2B) Quality Alliance, have successfully disseminated evidence-based strategies to reduce door-to-balloon time.1,2 Many hospital systems have achieved the targeted...

abstract background: acute coronary syndrome is one of the major cardiovascular diseases that leads to a significant amount of morbidity. the purpose of the present study was to investigate the effect of cardiac rehabilitation on quality of life in patients with acute coronary syndrome. materials and methods: this was a clinical trial study conducted on 50 patients with acute coronary syndrome ...

The year 2013 was rich of new developments in cardiology, and percutaneous coronary intervention (PCI) in particular. This overview article will focus on contributions in the following areas: training for PCI, appropriateness and indications; access site selection, risk scores, peri-procedural myocardial infarction; trial results and long-term follow-up; PCI for specific patient and lesion subs...

recommend Neuroimmunomodulation to anyone interested in gaining an introduction to an exciting field with a long future. Treatment for the patient with an acute myocardial infarction (AMI) has changed considerably in the past 50 years. Initially, the treatment simply consisted of rest. With the introduction of antiarrhythmics and coronary care units, mortality from AMI decreased substantially. ...

Background To be used optimally, new interventional devices (stent, lasers, atherectomy catheters) must be carefully evaluated in terms of optimal patient and lesion selection, technique of use, expected acute success and complications, and long-term results. Sources for that information include singlecenter and multicenter (single-device) reports, although randomized trials may then be perform...

M ultiple, large randomised trials comparing primary percutaneous coronary intervention (PCI) with fibrinolytic therapy for ST elevation myocardial infarction (STEMI) have shown that primary PCI results in lower rates of death, reinfarction, and stroke. Consequently, primary PCI has become the preferred reperfusion strategy for STEMI. Unfortunately, primary PCI is available in only a minority o...